Eilertsen, Anette L <br/><br/>
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.  [electronic resource] 

 -  Thrombosis and haemostasis  Jun 2007 
 - 938-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activated Protein C Resistance--blood<br/>Administration, Oral<br/>Blood Coagulation--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Combinations<br/>Estradiol--adverse effects<br/>Estrogen Receptor Modulators--administration & dosage<br/>Estrogen Replacement Therapy--adverse effects<br/>Female<br/>Humans<br/>Middle Aged<br/>Norethindrone--adverse effects<br/>Norethindrone Acetate<br/>Norpregnenes--administration & dosage<br/>Postmenopause--metabolism<br/>Protein C--metabolism<br/>Raloxifene Hydrochloride--administration & dosage<br/>Selective Estrogen Receptor Modulators--administration & dosage<br/>Tablets<br/>Thromboembolism--etiology<br/>Treatment Outcome<br/>Venous Thrombosis--etiology